TECHNOLOGY
Icagen's technology platform underlies the efficient discovery of all of Icagen's compounds currently in research or development. All of Icagen's compounds work by targeting ion channels. Over the past few years, discoveries related to the molecular structure of channels have advanced our understanding of how ion channels work. This new information has facilitated Icagen's drug discovery efforts. For more information on the Nobel prize winning work of Professor Roderick MacKinnon (Rockefeller University) and Professor Peter Agre (Johns Hopkins University) follow the link below:
Nobel Prize in Chemistry 2003 - Information for the Public
Ion Channels as Drug Targets
Ion channels play a critical role in many physiologic and pathophysiologic processes, thereby offering unique opportunities for intervention in the treatment of many major diseases.
Learn more >
Platform Technologies
Icagen has developed a broad array of platform technologies that enables the discovery of novel therapeutics targeting ion channels. Learn more >
|
|
